Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

20.7%

6 terminated/withdrawn out of 29 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

31%

9 trials in Phase 3/4

Results Transparency

67%

10 of 15 completed trials have results

Key Signals

10 with results6 terminated

Enrollment Performance

Analytics

N/A

12(52.2%)

Phase 4

9(39.1%)

Phase 1

1(4.3%)

Phase 2

1(4.3%)

23Total

N/A(12)

Phase 4(9)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (29)

Showing 20 of 29 trials

NCT04671888Not ApplicableUnknown

Chronic Obstructive Pulmonary Disease (COPD) Monitoring

Role: lead

NCT02755129Not ApplicableCompleted

FRailty WAlking Patterns (FRAP) Study

Role: lead

NCT01981590Not ApplicableCompleted

Mapping for Acute Transvenous Phrenic Nerve Stimulation Study

Role: lead

NCT02314598Terminated

Therapy Coil Electrogram Collection Study

Role: lead

NCT03242941Not ApplicableCompleted

AF Septal Pacing (Clinical Investigation Plan)

Role: lead

NCT01995552Not ApplicableCompleted

IdeNtifying High riSk Patients Post Myocardial Infarction With REduced Left Ventricular Function Using External Loop Recorders (INSPIRE-ELR Study)

Role: lead

NCT02140567Completed

Syncope Prediction Study

Role: lead

NCT03087084Not ApplicableUnknown

RESpiration deTection From Implanted Cardiac Devices in Subjects With Heart Failure (REST-HF)

Role: lead

NCT03245281Phase 4Unknown

LINQ for impEdance meAsuremeNt While Off From HF Medication Study

Role: lead

NCT02828735Not ApplicableCompleted

Respiration Patterns With Impedance in LINQ

Role: lead

NCT00401882Phase 2Terminated

Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial

Role: collaborator

NCT02301429Not ApplicableTerminated

Model 20105 Lead Study

Role: lead

NCT01088308Not ApplicableTerminated

Hemodynamic Differentiation of Tachycardia Episodes Using Tissue Perfusion

Role: lead

NCT02530203Not ApplicableTerminated

Spinal Cord Stimulation to Treat Post-operative Atrial Fibrillation

Role: lead

NCT00680927Phase 4Completed

Reveal® XT Performance Trial (XPECT)

Role: lead

NCT01509495Phase 1Terminated

Impedance Measurements in Heart Failure Patients

Role: lead

NCT01095952Not ApplicableCompleted

AV-node Stimulation Clinical Download Study to Reduce Ventricular Rate During AF

Role: lead

NCT00239226Phase 4Completed

Electrophysiologically Guided PAcing Site Selection Study

Role: lead

NCT00680550Completed

INSIGHT (R)XT. Indications for Diagnosis, Arrhythmia and Monitoring of Reveal XT

Role: lead

NCT01956578Not ApplicableUnknown

REVEAL for Respiration Detection

Role: lead